Artificial intelligence isn't just speeding up early-stage drug development, it's starting to unlock millions of dollars' ...

Real-world studies assess treatment effectiveness and patient experience beyond clinical trial settings, considering broader patient populations. Clinical trials have stricter enrollment criteria, ...

Signature Biologics, a clinical-stage cell therapy company committed to rigorous clinical research and to the DMD community, today announced that the U.S. Food and Drug Administration (FDA) has ...

Enrollment by Minneapolis Heart Institute Foundation at Abbott Northwestern Hospital marks a significant milestone in the ...

Haut.AI launches its Clinical Studies Software, a validated platform that measures 48 face, body and hair biomarkers and ...

Advancing a pipeline of in vivo CAR-T product candidates for oncology and immunology applications differentiated by CD7-targeted mRNA/LNP delivery approach Lead candidate TPST-4003 combines ...